Figure 7From: Evaluating the Suitability of Using Rat Models for Preclinical Efficacy and Side Effects with Inhaled Corticosteroids Nanosuspension FormulationsMulti-day side effects study (N = 10 for each group, presented with error bar as standard deviation) plasma drug exposures (2 h post the last dose)Back to article page